Mudanças entre as edições de "Alisertib Developers Unite"

De Mundo Sirrus
Ir para: navegação, pesquisa
(Alisertib Developers Unite)
(Sem diferença)

Edição atual tal como às 07h59min de 15 de fevereiro de 2020

Nucleic Fatty acids Ers 2012, Forty:e100.PubMedCrossRef Twenty. Krueger P oker, Kreck T, Franke A, Andrews SR: DNA Alisertib methylome examination making use of brief bisulfite sequencing information. Nat Approaches The coming year, Being unfaithful:145�C151.PubMedCrossRef Twenty one. Li H, Handsaker W, Wysoker A, Fennell Capital t, Ruan J, Homer D, Marth Gary, Abecasis G, Durbin R: The Sequence Alignment/Map format as well as SAMtools. Bioinformatics 2009, Twenty-five:2078�C2079.PubMedCrossRef 22. Krueger F ree p, Andrews SR: Bismark: a flexible type of aligner as well as methylation caller regarding Bisulfite-Seq programs. Bioinformatics 2011, Twenty-seven:1571�C1572.PubMedCrossRef Twenty-three. Sunlight Z, Asmann YW, Kalari KR, Bot B, Eckel-Passow On, Chef TR, Carr JM, Khrebtukova My spouse and i, Luo Azines, Zhang T, Schroth Doctor, Perez Ea, Thompson Expert advisor: Built-in evaluation associated with gene expression, CpG tropical isle methylation, as well as gene backup amount throughout cancers of the breast cellular material by heavy sequencing. PloS 1 The new year, Some:e17490.PubMedCrossRef 24. truck 't Steer LJ, Dai , vehicle delaware Vijver MJ, He YD, Hart AAM, Mao M, Peterse HL, van som Kooy E, Marton MJ, Witteveen With, Schreiber GJ, Kerkhoven RM, Roberts Chemical, Linsley Dsi, Bernards Ur, Friend SH: Gene phrase profiling states medical outcome of cancer of the breast. Dynamics 2000, 415:530�C536.PubMedCrossRef Twenty five. Sotiriou H, FLT3 inhibitor Neo S-Y, McShane Ulti-level marketing, Korn EL, Long Pm, Jazaeri Any, Martiat G, He Senate bill, Harris Ing, Liu Ainsi que: Cancers of the breast group and also diagnosis based on gene appearance profiles from the population-based examine. Proc Natl Acad Sci USA 2002, One hundred:10393�C10398.PubMedCrossRef Twenty six. Subsequent version. New York, United states of america, Springer; 2002. 27. Esteller M, Hammer toe Selleckchem RG7420 PG, Baylin SB, Herman JG: Any gene hypermethylation profile of individual cancer malignancy. Most cancers Ers Mid 2001, Sixty one:3225�C3229.PubMed 28. Baylin SB, Herman JG: Genetic make-up hypermethylation in tumorigenesis: epigenetics brings together genes. Styles Genet Year 2000, 07:168�C174.PubMedCrossRef 30. Costello JF, Fr��hwald Master of ceremonies, Smiraglia Disk jockey, Hurry LJ, Robertson Doctor, Gao By, Wright FA, Feramisco JD, Peltom?ki S, Lang JC, Schuller Signifiant, Yu T, Bloomfield Disc, Caligiuri MA, Yates Any, Nishikawa Ur, Su Huang H, Petrelli Nj-new jersey, Zhang A, O'Dorisio MS, Used Oregon, Cavenee WK, Plass C: Aberrant CpG-island methylation offers non-random and also tumour-type-specific habits. Nat Genet The year 2000, Twenty-four:132�C138.PubMedCrossRef 40. Doi The, Recreation area I-H, Wen N, Murakami R, Aryee MJ, Irizarry 3rd r, Botanical herb T, Ladd-Acosta C, Rho L, Loewer Ersus, Cooper J, Schlaeger T, Daley GQ, Feinberg Elp: Differential methylation involving tissue- as well as cancer-specific CpG isle shores differentiates human being induced pluripotent originate cells, embryonic originate cellular material and also fibroblasts. Nat Genet '09, Forty one:1350�C1353.PubMedCrossRef 31st. Wang H-Q, Tuominen LK, Tsai C-J: Slender: the moving linear model for estimating the percentage regarding genuine zero practices throughout datasets using dependence structures. Bioinformatics 2011, 27:225�C231.PubMedCrossRef Thirty two.